Call us with no obligation at: (800) 778-9905

Have a Birth Defect Question?

Enter your information below and we will answer your question as soon as possible.

Call Us with no obligation at:
(800) 778-9905


Generic: Flucanozole
Approved to treat: Fungal or yeast infections
Drug category: Antifungal drug
Year approved: 1990
Manufacturer: Pfizer

Babies who are prenatally (before birth) exposed to Diflucan may be at risk for developing birth defects, including:

  • Abnormal Skull or Face Formation
  • Cleft Lip/Palate
  • Head Deformity or Brachycephaly, also known as flat head syndrome
  • Bent Thigh Bones or Femoral Bowing
  • Joint Deformities
  • Congenital Heart Disease

FDA Warns Consumers about Link Between Diflucan Exposure and Birth Defects

The U.S. Food and Drug Administration (FDA) moved Diflucan from a Class C to a Class D drug, which means that there is evidence that shows a link between use of the drug and fetal risk. The regulatory agency stated that high doses of Diflucan (between 400 and 800 mg a day) during the first trimester of pregnancy may be associated with a rare and distinct set of birth defects in infants. While the risk varies for each defect, it is important to note that pregnant women should be warned of these dangerous and potentially serious side effects before they are prescribed this medication.

Birth Defect Resource website contains articles and content developed by medical professionals and other writers. The content provided by is intended for educational purposes only. Such content is not intended to, and does not, constitute medical or healthcare advice or diagnosis, and may not be used for such purposes. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Reliance on such information provided by is at your own risk.

Copyright © 2018 Birth Defect Resource. All rights reserved.